Compare CODA & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODA | FONR |
|---|---|---|
| Founded | 1994 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.4M | 119.0M |
| IPO Year | 2007 | 1995 |
| Metric | CODA | FONR |
|---|---|---|
| Price | $11.66 | $18.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 126.8K | 53.8K |
| Earning Date | 06-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.62 | N/A |
| EPS | 0.08 | ★ 1.16 |
| Revenue | $20,316,161.00 | ★ $104,351,318.00 |
| Revenue This Year | $18.28 | N/A |
| Revenue Next Year | $12.62 | N/A |
| P/E Ratio | $148.19 | ★ $16.27 |
| Revenue Growth | ★ 4.98 | 1.43 |
| 52 Week Low | $5.98 | $13.05 |
| 52 Week High | $18.00 | $18.95 |
| Indicator | CODA | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 62.45 |
| Support Level | $10.81 | $18.31 |
| Resistance Level | $12.22 | $18.95 |
| Average True Range (ATR) | 0.51 | 0.04 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 51.68 | 39.29 |
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.